Reckitt Benckiser Group (LON:RKT) PT Lowered to GBX 5,177

Reckitt Benckiser Group (LON:RKT) had its price target dropped by stock analysts at Berenberg Bank from GBX 5,200 ($67.51) to GBX 5,177 ($67.22) in a note issued to investors on Wednesday, Marketbeat reports. The brokerage currently has a “hold” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 6.50% from the company’s current price.

Other equities research analysts have also recently issued reports about the company. Jefferies Financial Group restated a “hold” rating and set a GBX 4,400 ($57.13) target price on shares of Reckitt Benckiser Group in a research report on Monday, July 29th. JPMorgan Chase & Co. downgraded Reckitt Benckiser Group to a “neutral” rating in a research report on Friday, August 30th.

Reckitt Benckiser Group Stock Performance

Shares of LON RKT opened at GBX 4,861 ($63.11) on Wednesday. The company has a market capitalization of £33.60 billion, a PE ratio of 2,261.29, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09. The company has a debt-to-equity ratio of 112.52, a quick ratio of 0.46 and a current ratio of 0.69. The company’s fifty day moving average price is GBX 4,532.62 and its 200 day moving average price is GBX 4,420.32. Reckitt Benckiser Group has a 1 year low of GBX 4,034 ($52.38) and a 1 year high of GBX 5,950 ($77.25).

Insider Activity

In related news, insider Fiona Dawson bought 25 shares of the business’s stock in a transaction dated Wednesday, October 23rd. The stock was acquired at an average price of GBX 4,923 ($63.92) per share, with a total value of £1,230.75 ($1,597.96). Company insiders own 0.05% of the company’s stock.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.